Soros Fund Management LLC Takes $39.41 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Soros Fund Management LLC acquired a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 77,913 shares of the healthcare conglomerate’s stock, valued at approximately $39,413,000.

A number of other large investors have also made changes to their positions in the stock. Sugarloaf Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 17.6% in the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock valued at $4,025,000 after purchasing an additional 1,193 shares in the last quarter. Signal Advisors Wealth LLC increased its holdings in shares of UnitedHealth Group by 13.0% in the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock valued at $4,611,000 after acquiring an additional 1,051 shares during the last quarter. Waycross Partners LLC increased its holdings in shares of UnitedHealth Group by 2.4% in the 4th quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock valued at $14,060,000 after acquiring an additional 658 shares during the last quarter. Czech National Bank lifted its stake in UnitedHealth Group by 6.1% in the fourth quarter. Czech National Bank now owns 199,536 shares of the healthcare conglomerate’s stock valued at $100,937,000 after buying an additional 11,426 shares during the last quarter. Finally, Lmcg Investments LLC lifted its position in UnitedHealth Group by 11.8% in the 4th quarter. Lmcg Investments LLC now owns 37,974 shares of the healthcare conglomerate’s stock valued at $19,210,000 after purchasing an additional 4,022 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on UNH shares. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. JPMorgan Chase & Co. lowered their price objective on shares of UnitedHealth Group from $652.00 to $525.00 and set an “overweight” rating on the stock in a research report on Thursday, April 24th. Argus cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, April 21st. Raymond James restated a “strong-buy” rating and set a $540.00 target price (down previously from $635.00) on shares of UnitedHealth Group in a research note on Monday, April 21st. Finally, Mizuho increased their target price on shares of UnitedHealth Group from $600.00 to $650.00 and gave the company an “outperform” rating in a research note on Wednesday, April 9th. Three analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and three have issued a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $603.05.

UnitedHealth Group Price Performance

UNH stock opened at $420.04 on Tuesday. The firm’s 50-day moving average price is $501.46 and its two-hundred day moving average price is $532.94. UnitedHealth Group Incorporated has a 12-month low of $412.02 and a 12-month high of $630.73. The stock has a market capitalization of $382.33 billion, a price-to-earnings ratio of 27.10, a PEG ratio of 1.37 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter in the prior year, the firm earned $6.91 earnings per share. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 2.00%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s payout ratio is 35.18%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.